MEMOMETAL TECHNOLOGIES – Trademark Portfolio

Entity Type: 99

MEMOMETAL TECHNOLOGIES holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 15 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MEMODERM and SMART TOE. The owner is based in BRUZ.

Campus de Ker Lann -

Rue Blaise Pascal

BRUZ F35170 , FR

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MEMOMETAL TECHNOLOGIES's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (15 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does MEMOMETAL TECHNOLOGIES have?

MEMOMETAL TECHNOLOGIES has 16 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.

What trademark classes does MEMOMETAL TECHNOLOGIES file in?

MEMOMETAL TECHNOLOGIES files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are MEMOMETAL TECHNOLOGIES's most well-known trademarks?

MEMOMETAL TECHNOLOGIES's registered trademark portfolio includes well-known marks such as MEMODERM and SMART TOE. These are among 2 currently registered trademarks in the portfolio.

What is MEMOMETAL TECHNOLOGIES's trademark registration success rate?

MEMOMETAL TECHNOLOGIES has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.